Status:
COMPLETED
Treatment of Periodontal Intrabony Defects With A-PRF+ or EMD
Lead Sponsor:
Semmelweis University
Conditions:
Periodontal Diseases
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of this randomized clinical trial was to clinically evaluate and compare the healing of intrabony defects after treatment with advanced platelet-rich fibrin (A-PRF+) to enamel matrix derivativ...
Detailed Description
Thirty (30) intrabony defects of 18 patients (9 males, 9 females) were randomly divided in two treatment groups: test (n = 15) and control (n = 15). The intrabony defects were filled with A-PRF+ (n=15...
Eligibility Criteria
Inclusion
- no systemic diseases that could influence the outcome of the therapy, a good level of oral hygiene, he presence of a 2-, 3-, or combined 2-3-wall intrabony defect with a defect angle of 20-40 (+/- 5) degrees, with a minimum PPD of 6 mm and intrabony component of a minimum 4 mm as detected on radiographs, no smoking
Exclusion
- systemic diseases that could influence the outcome of the therapy, poor oral hygiene, smoking, horizontal bone loss
Key Trial Info
Start Date :
June 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04404374
Start Date
June 27 2018
End Date
December 31 2020
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semmelweis University, Department of Periodontology
Budapest, Hungary, 1088